Cardinal Health, Inc. (CAH) 股票分析

公司概述

Cardinal Health, Inc. functions as a comprehensive healthcare services and products entity, serving markets across the United States and internationally through specialized segments in pharmaceuticals, specialty solutions, and global medical product distribution. This operational scope places the firm squarely within the Healthcare sector, specifically the Medical Distribution industry, where it facilitates the supply chain for hospitals and healthcare providers. The company commands a substantial market capitalization of $50.78B, supported by a trailing twelve-month revenue of $244.67B and an active workforce of 53,084 employees. These valuation and revenue figures indicate that Cardinal Health operates as a dominant market player with significant scale, leveraging its extensive network to influence pricing and availability within the complex medical distribution landscape.

财务健康

The company reported a revenue of $244.67B for the trailing twelve months, generating net income of $1.66B and an EBITDA of $3.82B, which highlights a distinct gap between top-line sales and bottom-line profitability that reveals a highly leveraged cost structure typical of low-margin distribution models. Free cash flow stands at $5.44B, providing the organization with considerable financial flexibility to fund operations, manage debt obligations, or invest in logistics infrastructure despite the thin profit margins. The margin profile is characterized by a gross margin of 3.7%, an operating margin of 1.2%, and a profit margin of 0.7%, indicating that the business model relies on high volume rather than per-unit profitability to generate earnings. On the balance sheet, cash reserves of $2.78B are compared against total debt of $9.03B, while the debt-to-equity ratio is not applicable in the provided data, suggesting a capital structure heavily reliant on debt financing. Liquidity is constrained with a current ratio of 0.91, which indicates that current assets are insufficient to cover current liabilities without relying on external financing or asset sales. Return on assets is recorded at 3.5%, while return on equity is not available, offering a limited view of management effectiveness specifically regarding shareholder equity returns but confirming efficient asset utilization relative to the low operating margins.

估值评估

Valuation multiples for Cardinal Health show a trailing P/E ratio of 31.05 compared to a forward P/E of 18.64, implying that the market expects significant earnings growth in the coming years to justify the current high multiple relative to future projections. The price-to-book ratio is listed as -17.66, a negative figure that suggests the market is pricing the company below its book value, likely due to the intangible nature of its assets or specific accounting treatments regarding its distribution network. Alternative metrics such as the price-to-sales ratio of 0.21 and an EV/EBITDA of 14.97 provide a more normalized view of the company's valuation relative to its massive revenue base and operating cash generation capabilities. The stock has traded within a 52-week range between a low of $121.17 and a high of $233.60, with the current valuation reflecting a position that requires context regarding recent market volatility to determine precise relative standing. The beta of 0.65 indicates that the stock exhibits lower volatility than the broader market, making it a less sensitive investment to general market swings compared to higher-beta technology or growth stocks.

Growth & Income

Revenue growth year-over-year is recorded at 18.8%, while earnings growth year-over-year stands at 19.4%, demonstrating that earnings are expanding at a slightly faster rate than revenue, which implies potential improvements in operating leverage or margin expansion over time. As a dividend payer, the company offers a yield of 0.9% with a payout ratio of 29.3%, a conservative level that suggests the dividend is highly sustainable given the company's earnings trajectory and cash flow generation. The low payout ratio allows the firm to retain a significant portion of earnings for reinvestment in its logistics network and product portfolio rather than distributing all profits to shareholders. Overall, the company presents a growth and income profile characterized by double-digit revenue expansion, efficient earnings growth, and a low-risk dividend strategy supported by a conservative payout ratio.